Lifeboat Foundation

Only two years ago, when I launched my advocacy website Rejuvenaction, I didn’t think I would read a book like Juvenescence so soon; yet, the topic of rejuvenation biotechnologies has already become mainstream enough to lead investors of the calibre of Jim Mellon and Al Chalabi to devote a whole book to it.

As Juvenescence is a book aimed at potential new investors in rejuvenation biotechnologies, I expected it to be an extremely technical and detailed account of things I don’t understand, such as finance, markets, and funds. To my delight, this was not the case. Rather, the details Juvenescence dives into are primarily those of the emerging field of rejuvenation science (alas, still something whose details I don’t fully understand).

The book explains the paradigm shift that is currently taking place and changing the way science sees aging—no longer as an inevitable fact of life but rather as a disease to be eradicated like any other—and goes through a biology 101 crash course for the benefit of readers who might be not too well versed in the science of life.

A Chinese team corrected the potentially fatal blood disorder beta-thalassemia.

Watch We Can Now Grow Human Bones From Stem Cells, a Biotech video from Seeker.

A new mouse study by University of Florida Health researchers shows that multiple sclerosis can be inhibited or even reversed by using a gene therapy that stops the immune response caused by the disease in its tracks.

What is multiple sclerosis?

Multiple sclerosis (MS) is an autoimmune disease, affects around 2.3 million people worldwide and is the most common neurological disease in young adults. The average life expectancy for people with MS is around 6 to 7 years lower than the norm[1]. This lifelong condition begins when the immune system attacks the myelin sheath surrounding nerve.

Out of necessity, Japan has been pushing on the robotics frontier for years. As a result, the proliferation and embrace of robots goes well beyond the Japanese factory floor to include schools, hospitals, nursing homes, airports, train stations and even temples.

Unfavourable demographics are spurring innovation — and investment opportunities.

I did a new interview on #transhumanism for some journalism students at Germany’s Technical University of Dortmund. It’s in English:

Mechanical bodyparts are very common nowadays – a lot of humans have a hip replacement or a pacemaker. Technology helps saving our lives rather often. Some people want to take this a lot further – a philosophical and scientific movement called Transhumanism. Zoltan Istvan Gyurko is one of the most famous Transhumanists, he even ran for president in 2016. In this interview, he talks about his first experiences with Transhumanism, immortality and the future of humanity.

By Marie-Louise Timcke und Paul Klur

Continue reading “Humanity will be lost” »

So far, the only intervention that is known to increase lifespan in multiple species is caloric restriction (CR). Caloric restriction is known to increase lifespan in the majority of mouse strains tested[1]. The effects of CR have even been shown to influence how primates age and reduce the incidence of diabetes, cancer, cardiovascular disease, and brain atrophy[2].

Science has known about the effects of CR since the 1930s, when rat experiments first showed researchers this phenomenon[3]. However, despite the various health benefits of CR, how it delays aging has remained a mystery. A new study suggests that epigenetic drift may be the answer.

On July 18, 2017 Japan lost a national treasure. He was the 105-year-old Dr. Shigeaki Hinohara.

Dr. Hinohara made a lion’s contribution to healthcare in Japan, both as a practicing medical doctor and as a physician. He headed five foundations in addition to being the president of St Luke’s International Hospital in Tokyo. He was responsible for introducing Japan’s system of comprehensive annual medical check-ups, which have been credited with greatly contributing to the country’s longevity, reports the BBC.

Those are laudable achievements, but it is his longevity and the fact that he saw patients until a few months before his death that defies everything we have come to expect of old age.

Continue reading “A Japanese doctor who studied longevity — and lived to 105 — reveals the key to living a long life” »